Cargando…
Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine
BACKGROUND: Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular diseases (CVDs). Stachydrine (STA) is an active component in Chinese motherwort Leonurus heterophyllus sweet, which has been widely used for gynecological and cardiovascular disorders. This study is aimed to exa...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016886/ https://www.ncbi.nlm.nih.gov/pubmed/30134790 http://dx.doi.org/10.1186/s10020-018-0010-0 |
_version_ | 1783334624227753984 |
---|---|
author | Xie, Xinya Zhang, Zihui Wang, Xinfeng Luo, Zhenyu Lai, Baochang Xiao, Lei Wang, Nanping |
author_facet | Xie, Xinya Zhang, Zihui Wang, Xinfeng Luo, Zhenyu Lai, Baochang Xiao, Lei Wang, Nanping |
author_sort | Xie, Xinya |
collection | PubMed |
description | BACKGROUND: Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular diseases (CVDs). Stachydrine (STA) is an active component in Chinese motherwort Leonurus heterophyllus sweet, which has been widely used for gynecological and cardiovascular disorders. This study is aimed to examine the effects of STA on homocysteine (Hcy)-induced endothelial dysfunction. METHODS: The effects of STA on vascular relaxation in rat thoracic aortas (TA), mesenteric arteries (MA) and renal arteries (RA) were measured by using Multi Myograph System. The levels of nitric oxide (NO), tetrahydrobiopterin (BH4) and guanosine 3′, 5′ cyclic monophosphate (cGMP) were determined. Endothelial nitric oxide synthase (eNOS) dimers and monomers were assayed by using Western blotting. GTP cyclohydrolase 1 (GTPCH1) and dihydrofolate reductase (DHFR) expressions were measured by using quantitative reverse transcriptase-PCR (qRT-PCR) and Western blotting. RESULTS: STA effectively blocked Hcy-induced impairment of endothelium-dependent vasorelaxation in rat TA, MA and RA. STA-elicited arterial relaxations were reduced by NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME) or the NO-sensitive guanylyl cyclase inhibitor 1H- [1, 2, 4] Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), but not by inducible iNOS inhibitor 1400 W nor the nonselective COX inhibitor indomethacin. Hcy caused eNOS uncoupling and decreases in NO, cGMP and BH4, which were attenuated by STA. Moreover, STA prevented decreases of GTPCH1 and DHFR levels in Hcy-treated BAECs. CONCLUSION: We demonstrated that STA effectively reversed the Hcy-induced endothelial dysfunction and prevented eNOS uncoupling by increasing the expression of GTPCH1 and DHFR. These results revealed a novel mechanism by which STA exerts its beneficial vascular effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s10020-018-0010-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6016886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60168862018-07-05 Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine Xie, Xinya Zhang, Zihui Wang, Xinfeng Luo, Zhenyu Lai, Baochang Xiao, Lei Wang, Nanping Mol Med Research Article BACKGROUND: Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular diseases (CVDs). Stachydrine (STA) is an active component in Chinese motherwort Leonurus heterophyllus sweet, which has been widely used for gynecological and cardiovascular disorders. This study is aimed to examine the effects of STA on homocysteine (Hcy)-induced endothelial dysfunction. METHODS: The effects of STA on vascular relaxation in rat thoracic aortas (TA), mesenteric arteries (MA) and renal arteries (RA) were measured by using Multi Myograph System. The levels of nitric oxide (NO), tetrahydrobiopterin (BH4) and guanosine 3′, 5′ cyclic monophosphate (cGMP) were determined. Endothelial nitric oxide synthase (eNOS) dimers and monomers were assayed by using Western blotting. GTP cyclohydrolase 1 (GTPCH1) and dihydrofolate reductase (DHFR) expressions were measured by using quantitative reverse transcriptase-PCR (qRT-PCR) and Western blotting. RESULTS: STA effectively blocked Hcy-induced impairment of endothelium-dependent vasorelaxation in rat TA, MA and RA. STA-elicited arterial relaxations were reduced by NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME) or the NO-sensitive guanylyl cyclase inhibitor 1H- [1, 2, 4] Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), but not by inducible iNOS inhibitor 1400 W nor the nonselective COX inhibitor indomethacin. Hcy caused eNOS uncoupling and decreases in NO, cGMP and BH4, which were attenuated by STA. Moreover, STA prevented decreases of GTPCH1 and DHFR levels in Hcy-treated BAECs. CONCLUSION: We demonstrated that STA effectively reversed the Hcy-induced endothelial dysfunction and prevented eNOS uncoupling by increasing the expression of GTPCH1 and DHFR. These results revealed a novel mechanism by which STA exerts its beneficial vascular effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s10020-018-0010-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-19 /pmc/articles/PMC6016886/ /pubmed/30134790 http://dx.doi.org/10.1186/s10020-018-0010-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Xie, Xinya Zhang, Zihui Wang, Xinfeng Luo, Zhenyu Lai, Baochang Xiao, Lei Wang, Nanping Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine |
title | Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine |
title_full | Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine |
title_fullStr | Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine |
title_full_unstemmed | Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine |
title_short | Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine |
title_sort | stachydrine protects enos uncoupling and ameliorates endothelial dysfunction induced by homocysteine |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016886/ https://www.ncbi.nlm.nih.gov/pubmed/30134790 http://dx.doi.org/10.1186/s10020-018-0010-0 |
work_keys_str_mv | AT xiexinya stachydrineprotectsenosuncouplingandamelioratesendothelialdysfunctioninducedbyhomocysteine AT zhangzihui stachydrineprotectsenosuncouplingandamelioratesendothelialdysfunctioninducedbyhomocysteine AT wangxinfeng stachydrineprotectsenosuncouplingandamelioratesendothelialdysfunctioninducedbyhomocysteine AT luozhenyu stachydrineprotectsenosuncouplingandamelioratesendothelialdysfunctioninducedbyhomocysteine AT laibaochang stachydrineprotectsenosuncouplingandamelioratesendothelialdysfunctioninducedbyhomocysteine AT xiaolei stachydrineprotectsenosuncouplingandamelioratesendothelialdysfunctioninducedbyhomocysteine AT wangnanping stachydrineprotectsenosuncouplingandamelioratesendothelialdysfunctioninducedbyhomocysteine |